These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 26021642)

  • 1. Fluphenazine·HCl and Epigallocatechin Gallate Modulate the Rate of Formation and Structural Properties of Apolipoprotein C-II Amyloid Fibrils.
    Zlatic CO; Mao Y; Ryan TM; Mok YF; Roberts BR; Howlett GJ; Griffin MD
    Biochemistry; 2015 Jun; 54(24):3831-8. PubMed ID: 26021642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in disease-related apolipoprotein C-II amyloid fibrils: a structural model for rod-like fibrils.
    Zlatic CO; Mao Y; Todorova N; Mok YF; Howlett GJ; Yarovsky I; Gooley PR; Griffin MDW
    FEBS J; 2018 Aug; 285(15):2799-2812. PubMed ID: 29791776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shear flow induced changes in apolipoprotein C-II conformation and amyloid fibril formation.
    Teoh CL; Bekard IB; Asimakis P; Griffin MD; Ryan TM; Dunstan DE; Howlett GJ
    Biochemistry; 2011 May; 50(19):4046-57. PubMed ID: 21476595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charge and charge-pair mutations alter the rate of assembly and structural properties of apolipoprotein C-II amyloid fibrils.
    Mao Y; Teoh CL; Yang S; Zlatic CO; Rosenes ZK; Gooley PR; Howlett GJ; Griffin MD
    Biochemistry; 2015 Feb; 54(6):1421-8. PubMed ID: 25609257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
    Griffin MD; Mok ML; Wilson LM; Pham CL; Waddington LJ; Perugini MA; Howlett GJ
    J Mol Biol; 2008 Jan; 375(1):240-56. PubMed ID: 18005990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis.
    Wilson LM; Mok YF; Binger KJ; Griffin MD; Mertens HD; Lin F; Wade JD; Gooley PR; Howlett GJ
    J Mol Biol; 2007 Mar; 366(5):1639-51. PubMed ID: 17217959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoiding the oligomeric state: αB-crystallin inhibits fragmentation and induces dissociation of apolipoprotein C-II amyloid fibrils.
    Binger KJ; Ecroyd H; Yang S; Carver JA; Howlett GJ; Griffin MD
    FASEB J; 2013 Mar; 27(3):1214-22. PubMed ID: 23159935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Lipid in Misfolding and Amyloid Fibril Formation by Apolipoprotein C-II.
    Ryan TM; Mok YF; Howlett GJ; Griffin MD
    Adv Exp Med Biol; 2015; 855():157-74. PubMed ID: 26149930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity amphipathic modulators of amyloid fibril nucleation and elongation.
    Ryan TM; Griffin MD; Teoh CL; Ooi J; Howlett GJ
    J Mol Biol; 2011 Feb; 406(3):416-29. PubMed ID: 21185302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation.
    Stewart CR; Wilson LM; Zhang Q; Pham CL; Waddington LJ; Staples MK; Stapleton D; Kelly JW; Howlett GJ
    Biochemistry; 2007 May; 46(18):5552-61. PubMed ID: 17429947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of polymorphism in apolipoprotein C-II amyloid fibrils.
    Teoh CL; Yagi H; Griffin MD; Goto Y; Howlett GJ
    J Biochem; 2011 Jan; 149(1):67-74. PubMed ID: 20889492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra- and Intersubunit Ion-Pair Interactions Determine the Ability of Apolipoprotein C-II Mutants To Form Hybrid Amyloid Fibrils.
    Todorova N; Zlatic CO; Mao Y; Yarovsky I; Howlett GJ; Gooley PR; Griffin MD
    Biochemistry; 2017 Mar; 56(12):1757-1767. PubMed ID: 28229588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein C-II amyloid fibrils assemble via a reversible pathway that includes fibril breaking and rejoining.
    Binger KJ; Pham CL; Wilson LM; Bailey MF; Lawrence LJ; Schuck P; Howlett GJ
    J Mol Biol; 2008 Feb; 376(4):1116-29. PubMed ID: 18206908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen/Deuterium Exchange and Molecular Dynamics Analysis of Amyloid Fibrils Formed by a D69K Charge-Pair Mutant of Human Apolipoprotein C-II.
    Mao Y; Zlatic CO; Griffin MD; Howlett GJ; Todorova N; Yarovsky I; Gooley PR
    Biochemistry; 2015 Aug; 54(31):4805-14. PubMed ID: 26196342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methionine oxidation inhibits assembly and promotes disassembly of apolipoprotein C-II amyloid fibrils.
    Binger KJ; Griffin MD; Howlett GJ
    Biochemistry; 2008 Sep; 47(38):10208-17. PubMed ID: 18729385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-epigallocatechin-3-gallate inhibits fibrillogenesis of chicken cystatin.
    Wang N; He J; Chang AK; Wang Y; Xu L; Chong X; Lu X; Sun Y; Xia X; Li H; Zhang B; Song Y; Kato A; Jones GW
    J Agric Food Chem; 2015 Feb; 63(5):1347-51. PubMed ID: 25620201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E.
    Gunzburg MJ; Perugini MA; Howlett GJ
    J Biol Chem; 2007 Dec; 282(49):35831-41. PubMed ID: 17916554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cyclic peptide inhibitor of apoC-II peptide fibril formation: mechanistic insight from NMR and molecular dynamics analysis.
    Griffin MD; Yeung L; Hung A; Todorova N; Mok YF; Karas JA; Gooley PR; Yarovsky I; Howlett GJ
    J Mol Biol; 2012 Mar; 416(5):642-55. PubMed ID: 22244853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sedimentation Velocity Analysis of the Size Distribution of Amyloid Oligomers and Fibrils.
    Mok YF; Howlett GJ; Griffin MD
    Methods Enzymol; 2015; 562():241-56. PubMed ID: 26412655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice.
    Franko A; Rodriguez Camargo DC; Böddrich A; Garg D; Rodriguez Camargo A; Rathkolb B; Janik D; Aichler M; Feuchtinger A; Neff F; Fuchs H; Wanker EE; Reif B; Häring HU; Peter A; Hrabě de Angelis M
    Sci Rep; 2018 Jan; 8(1):1116. PubMed ID: 29348618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.